Ofer Agid, MD | Psychiatrist.com

Commentary

Treatment-Resistant Schizophrenia Guideline

March 5, 2019

Read expert commentary on guidelines for treatment-resistant schizophrenia (TRS) to make more informed treatment decisions.

John M. Kane, Ofer Agid, Marjorie L. Baldwin, et al

Meta-Analysis

Aripiprazole and Worsening Psychosis

March 6, 2018

Case reports suggest psychosis might worsen with a switch to or addition of aripiprazole. But is worsening just as likely with other antipsychotics? To answer this question, this government-supported...

Hiroyoshi Takeuchi, Ali Fathi, Sadhana Thiyanavadivel, et al

Article

Two Strategies for Switching to Clozapine

February 22, 2017

What's the best way to switch to clozapine in patients with treatment-resistant schizophrenia? Do you worry that efficacy and tolerability will be compromised? This pilot, double-blind RCT addresses your...

Hiroyoshi Takeuchi, Jimmy Lee, Gagan Fervaha, et al

Letter to the Editor

Efficacy of Auditory Processing-Focused Cognitive Remediation Therapy

October 26, 2016

Cynthia O. Siu, Ofer Agid

Original Research

Determinants of Patient-Rated and Clinician-Rated Illness Severity in Schizophrenia

July 22, 2015

Gagan Fervaha, Hiroyoshi Takeuchi, Ofer Agid, et al

Original Research

An Algorithm-Based Approach to First-Episode Schizophrenia: Response Rates Over 3 Prospective Antipsychotic Trials With a Retrospective Data Analysis

March 8, 2011

Ofer Agid, Tamara Arenovich, Gautam Sajeev, et al

Original Research

Triiodothyronine Augmentation of Selective Serotonin Reuptake Inhibitors in Posttraumatic Stress Disorder

March 1, 2001

Ofer Agid, Arieh Y. Shalev, Bernard Lerer

Letter to the Editor

Risperidone Augmentation of Paroxetine in a Case of Severe, Treatment-Refractory Obsessive-Compulsive Disorder Without Comorbid Psychopathology

January 31, 1999

Ofer Agid, Bernard Lerer